Prostate Cancer
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.
January 24, 2024
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.
January 24, 2024
Functional Outcomes After Localized Prostate Cancer Treatment
January 23, 2024
Long-Term Follow up Pinpoints Side Effects of Treatments for Prostate Cancer Patients
January 23, 2024
The effect of limited english proficiency on prostate-specific antigen screening in American men.
January 23, 2024
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET.
January 23, 2024
Oncologic Outcome of the Extent of Pelvic Lymph Node Dissection During Radical Prostatectomy: A Systematic Review, Meta-analysis, and Network Analysis.
January 23, 2024
Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
January 22, 2024
Palliative urologic surgery for metastatic prostate cancer: what needs to be considered in the future?.
January 22, 2024
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.
January 22, 2024
Impact of curative radiotherapy on the immune status of patients with localized prostate cancer.
January 22, 2024